The extended spectrum of RAS‐MAPK pathway mutations in colorectal cancer-Reference-Cited by-同舟云学术

The extended spectrum of RAS‐MAPK pathway mutations in colorectal cancer

Published:2019-10-14 Issue:3 Volume:59 Page:152-159
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Costigan Danielle C.¹,Dong Fei¹^ORCID

Affiliation:

1. Department of PathologyBrigham and Women's Hospital, Harvard Medical School Boston Massachusetts

Funder

American Association for Cancer Research

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/gcc.22813

Reference94 articles.

1. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology

2. BensenAB VenookAP Al‐HawaryMM et al. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. Version 2.2019. Available at:NCCN.org. Accessed June30 2019.

3. BensenAB VenookAP Al‐HawaryMM et al. NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. Version 2.2019. Available at:NCCN.org. Accessed June30 2019.

4. KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

5. K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-Cancer Molecular Biomarkers;Clinics in Laboratory Medicine;2024-06

2. Wnt3a is a promising target in colorectal cancer;Medical Oncology;2023-01-31

3. Role of SHP2/PTPN11 in the occurrence and prognosis of cancer: A systematic review and meta‑analysis;Oncology Letters;2022-11-22

4. Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations;Modern Pathology;2022-10

5. Somatic mutations in colorectal cancer: regional experience;Consilium Medicum;2022-07-15